Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $149.1800 (1.32%) ($147.1500 - $149.6600) on Tue. Oct. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.09% (three month average) | RSI | 32 | Latest Price | $149.1800(1.32%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -0.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) DIA(54%) IBB(54%) SPLV(50%) VYM(50%) | Factors Impacting ABBV price | ABBV will decline at least -0.545% in a week (0% probabilities). VXX(-37%) VIXM(-33%) USO(-27%) TBT(-23%) GLD(-22%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.545% (StdDev 1.09%) | Hourly BBV | 1 () | Intraday Trend | 1.1% | | | |
|
Resistance Level | $149.97 | 5 Day Moving Average | $148.4(0.53%) | 10 Day Moving Average | $148.35(0.56%) | 20 Day Moving Average | $149.97(-0.53%) | To recent high | -3.5% | To recent low | 10.6% | Market Cap | $263.196b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |